Background: Antibiotic resistance poses a significant threat to patients suffering from infectious diseases. Early readings of antibiotic susceptibility test (AST) results could be of critical importance to ensure adequate treatment. Disc diffusion is a well-standardized, established and cost-efficient AST procedure; however, its use in the clinical laboratory is hampered by the many manual steps involved, and an incubation time of 16-18 h, which is required to achieve reliable test results.
Introduction
Due to the continuous rise in antibiotic resistance, susceptibility patterns of bacterial infectious disease pathogens are becoming less predictable-a trend that is having a negative impact on patient healthcare. 1 Early and effective antibiotic treatment has been demonstrated to significantly improve clinical outcome and to reduce mortality. 2, 3 The time required for conventional antibiotic susceptibility tests (ASTs) can result in a significant delay in the administration of an effective drug: the likelihood of antibiotic resistance to the empirical therapy selected is increasing and timely information on antibiotic susceptibility becomes of particular importance. 4 Other consequences of unknown antibiotic resistance are the use of more toxic agents or an unnecessary broadspectrum therapy. 1 Rapid availability of accurate results from ASTs is currently considered one of the most important unmet medical needs in the management of infectious diseases. 5, 6 Automated microdilution ASTs provide results within 6-12 h but have a number of disadvantages, including fixed drug panels, low resolution (few drug concentrations tested), the need for a separate check for purity of culture, poor detection of synergism/antagonism phenomena, and comparably low sensitivity/specificity for important resistance mechanisms such as ESBLs, carbapenemases or inducible erm-mediated macrolide, lincosamide and streptogramin resistance (MLS). [7] [8] [9] Molecular detection of resistance determinants is rapid in principle, but hampered by the vast number of resistance mechanisms to cover. Molecular ASTs are, by nature, focused on specific genetic elements, making maintenance of accurate coverage, and hence detection of the most relevant resistance genes, a laborious task considering the different epidemiologies worldwide. 10 In addition, the presence of genes alone does not necessarily correlate with expression and phenotypic resistance.
Resistance detection by MALDI-TOF has also been described, but is limited to specific targets such as PBP2a, ESBLs or carbapenemases. [11] [12] [13] [14] Microfluidic systems have recently been described as a potential tool for performing rapid ASTs within 6 h from blood culture broth. 15 Both techniques, however, are still in their infancy, and currently not designed for high-throughput ASTs.
Disc diffusion is still an affordable, accurate, reliable and highly standardized AST method with the advantages of low consumable costs, flexible drug testing and recognition of additional phenomena such as synergisms for the detection of ESBLs and/or antagonisms for the detection of ermMLS or AmpCs. [16] [17] [18] [19] However, the standard incubation time recommended in CLSI and EUCAST guidelines is 16-18 h for most pathogens. 20, 21 This study aimed at analysing the technical feasibility of a rapid disc diffusion AST (rAST), comprising early disc diffusion zone diameter reading at 6-12 h using the fully automated WASPLab TM system (Copan Italia). 22 The study focused on the utility of earlier (,18 h) readings, the influence of early reading on precision/reproducibility and the influence of early reading on categorical agreement with EUCAST 18 h clinical breakpoints (CBPs) for pathogens that are most prevalent in positive blood cultures/sepsis.
Methods

Quality control (QC) strains
For testing methodological precision and accuracy, 59 repetitive disc diffusion ASTs of Escherichia coli ATCC 25922 and 58 repetitive disc diffusion ASTs of Staphylococcus aureus ATCC 29213 EUCAST QC strains were done from individual fresh subcultures and individually prepared 0.5 McFarland standards. Interpretation was done according to EUCAST QC tables version 6.1.
23
Clinical isolates
Study isolates were selected to cover a broad range of inhibition zone diameters for each species/drug combination tested (see Figure S1 , available as Supplementary data at JAC Online). In particular, critical isolates close to the CBPs were included. All non-duplicate clinical strains included in this study were isolated over a 3 year period from 2013 to 2016 in the clinical microbiology laboratory of the Institute of Medical Microbiology, University of Zurich. Isolates of the same species were considered duplicate(s) if they: (i) originated from the same patient; and (ii) showed no more that one major and two minor differences in AST interpretation. The following numbers of clinical isolates were tested: E. coli (n " 291), Klebsiella pneumoniae (n " 272), S. aureus (n " 176) and Staphylococcus epidermidis (n " 289).
Susceptibility testing
Susceptibility testing and clinical categorization was performed according to EUCAST guidelines version 6.0, which are essentially the same standards as CLSI 2016. 20, 21 In brief, bacterial suspensions were manually adjusted to a turbidity equivalent to that of a 0.5 McFarland standard and processed within 15 min. Mueller-Hinton II agar plates (Oxoid Ltd, Basingstoke, UK) were processed in the fully automated WASP TM system (Copan Italia SpA, Brescia, Italy), i.e. plates were each inoculated with 60 lL of the bacterial suspension and automatically streaked. Antibiotic discs of a single production lot (Oxoid) were placed using a standard distributor, which was handled by the WASP TM robot immediately after plate streaking. Subsequently, plates were automatically transported to and incubated in a WASPLab TM incubator (Copan) at 37 + 2 C in ambient air. Images were taken after 6, 8, 12 and 18 h of incubation under continuous temperature conditions. Diameter measurements were automatically done by the WASPLab TM reading software (Copan) and were, if necessary, adjusted onscreen by an experienced technician.
Statistical analysis and software
All statistical analyses were performed using R, version 3.2.3. 24 For the QC strains, significance of deviations from target values issued by EUCAST was assessed using one-sample t-tests with the Bonferroni correction (a " 0.05). Linear mixed models were used to model the influence of reading time on reading precision. The antibiotic was treated as a random effect and the R package nlme, version 3.1-128, was used. 25 For S. aureus ATCC 29213 a paired t-test was used to test whether precision at 6 h was significantly different from the mean precision at later reading times. For the clinical isolates, readability and categorical agreement with reading after 18 h were analysed using logistic regression with reading time, species and antibiotic as predictors. Significance of coefficients was assessed using likelihood-ratio tests.
Results
Methodological precision and accuracy
The methodological precision of the disc diffusion AST was assessed using EUCAST QC strains E. (Table 1) . 23 The methodological precision of early reading was within +0.2 mm of that of the 18 h standard incubation time except for the S. aureus ATCC 29213 6 h reading: the average 1-fold standard deviation of all drugs tested at 18 h was 0.9 mm for E. coli ATCC 25922 and 0.7, 0.7 and 0.8 mm for the 6, 8 and 12 h readings, respectively; the observed increase of standard deviation over time was thus small (0.2 mm), but was statistically significant (P " 0.003; Table 1 ). The 1-fold standard deviation of all drugs tested at 18 h was 1.1 mm for S. aureus ATCC 29213 and 5.1, 1.2 and 1.2 mm for the 6, 8 and 12 h readings, respectively. The standard deviation was significantly higher at 6 h as compared with later reading times (P " 1 % 10
#07
) and no statistical evidence for systematic change in precision for later reading times was found (P " 0.08; Table 1 ).
In addition, we assessed calibration of the test system to given EUCAST targets: at 18 h of incubation, the mean diameter values of 11 out of 18 drugs and E. coli ATCC 25922 matched EUCAST target values or deviated by 1 mm (81.0%); for 7 drugs (19%) the mean diameter values deviated 2 mm from the target ( Table 1) . 26 For S. aureus ATCC 29213 6 out of 16 drugs (37.5%) deviated 0-1 mm from the EUCAST target, 6 drugs deviated 2 mm from target and for 4 drugs (penicillin G, tobramycin, tetracycline and tigecycline) the mean diameter values deviated 3 mm from the EUCAST target.
Readability
Readability was defined as the percentage of data points for which a diameter measurement could reliably be determined. The following antibiotics were tested for Enterobacteriaceae and read at 6, 8, 12 and 18 h: ampicillin (E. coli only), amoxicillin/clavulanate, piperacillin/tazobactam, cefuroxime, cefoxitin, cefpodoxime, Hombach et al. Table 1 . 
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Rapid disc diffusion susceptibility testing JAC Table 1 . Rapid disc diffusion susceptibility testing JAC ceftriaxone, cefepime, meropenem, norfloxacin, ciprofloxacin, levofloxacin, amikacin, gentamicin, tobramycin, tigecycline, nitrofurantoin (E. coli only) and trimethoprim/sulfamethoxazole. The following antibiotics were tested for staphylococci and read at 6, 8, 12 and 18 h: penicillin G (S. aureus only), cefoxitin, norfloxacin, ciprofloxacin, levofloxacin, gentamicin, tobramycin, clindamycin, erythromycin, tetracycline, minocycline, tigecycline, linezolid, fusidic acid, rifampicin and trimethoprim/sulfamethoxazole, resulting in a total of 66 964 data points, i.e. 20 952, 17 408, 11 264 and 17 340 data points for E. coli (n " 291), K. pneumoniae (n " 272), S. aureus (n " 176) and S. epidermidis (n " 289), respectively. Logistic regression was used to model observed readabilities and a significant increase in readability over time was found (P , 2 % 10 #16 ). In addition, significant differences between species were observed (P , 2 % 10 #16 ). Average readability at early timepoints was, in part, higher for E. coli and K. pneumoniae than for S. aureus and S. epidermidis (99.4%, 99.0%, 82.2% and 19.8% at 6 h, respectively; 100%, 99.6%, 97.9%, 97.9% and 63.8% at 8 h, respectively; and 100%, 100%, 100% and 99.4% at 12 h, respectively; Table 2 ). While there were only minor variations between readability of individual drugs for the Enterobacteriaceae, readability of different drugs for staphylococci ranged from 62.5% for tetracycline to 96.6% for norfloxacin (S. aureus at 6 h; Table 2 ) and from 10.7% for tetracycline to 41.2% for erythromycin and clindamycin (S. epidermidis at 6 h).
Categorical agreement
Categorical agreement of early readings increased significantly over time when EUCAST 18 h CBPs were applied (P , 2 % 10 #16 ): the average agreement for clinical strains and all drugs tested at 6 h was 93.5%, 93.3%, 48.7% and 77.5% for E. coli, K. pneumoniae, S. aureus and S. epidermidis, respectively, and increased to 96.6%, 95.9%, 88.8% and 89.3% at 8 h and to 98.7%, 98.4%, 99.0% and 97.2% at 12 h (Table 2 ).
Significant differences were observed between species (P , 2 % 10 #16 ) and between individual drugs (P , 2 % 10 #16 ), e.g. categorical agreement at 6 h varied from 82.3% for trimethoprim/sulfamethoxazole to 99.7% for ampicillin and meropenem in E. coli, from 13.8% for minocycline to 97.8% for trimethoprim/sulfamethoxazole in S. aureus, and from 66.7% to 96.6% for levofloxacin and norfloxacin for the quinolones in S. aureus at 8 h ( Table 2) .
Change of zone diameters over time and interpretation errors
The majority of inhibition zone diameter values changed over time (see examples in Figure 1 and change patterns in Table 2 ). Decreasing, increasing and stable zone diameter patterns were observed for all species/drug combinations ( Table 2 ). Most frequently, different diameter change patterns were observed in one and the same species/drug combination (see examples in Figure 1 ) and no clear correlation of a diameter change pattern and a specific drug or drug class was detected ( Table 2) .
Changes of zone diameters would result in interpretation errors at early reading times when applying EUCAST 18 h CBPs: increasing diameters were the most frequent pattern and resulted in major errors or minor errors depending on the relative position of the CBP, e.g. 70.1% major errors for cefoxitin and S. aureus at 6 h, and 12.9% minor errors for E. coli and norfloxacin at 6 h ( Table 2 and Figure 1 ). Decreasing diameters resulted in very major errors, e.g. 11.1% very major errors for trimethoprim/sulfamethoxazole and E. coli at 6 h ( Table 2) .
Discussion
Automation of disc diffusion has been demonstrated to significantly improve standardization and to reduce manual workload. [27] [28] [29] In addition to offering improved standardization, this study demonstrates that automated disc diffusion in principle allows for early reading for the most important pathogens isolated from positive blood cultures, e.g. E. coli, K. pneumoniae, S. aureus and S. epidermidis accounted for 39.6% of all blood culture isolates in our laboratory in 2015. Most importantly, early reading did not impair methodological precision ( Table 1) . As zone diameters were adjusted on-screen an investigator-bias to better match QC requirements is theoretically possible. However, technicians did not have any information on the appropriate QC ranges next to them during zone reading. It seems unlikely that a person will be able to recall the high number of QC ranges and use this information to intentionally bias results.
The optimal early reading timepoints varied according to the species studied. The vast majority of zone diameters of E. coli and K. pneumoniae were readable after 6 h of incubation, while reliable reading for S. aureus was possible after 8 h and sufficient readability for S. epidermidis zones was achieved after 12 h of incubation (Table 2) . Therefore, early reading times need to be adjusted to the species being analysed.
Zone diameters changed over time, leading to both major errors (false-resistant results) and very major errors (falsesusceptible results) if CLSI-and EUCAST-recommended CBPs for 18 h incubation were applied (Table 2 and Figure 1 ). The patterns of diameter changes varied from decreasing diameters over stable zones to increasing diameters, and the change patterns were, in part, species/drug combination dependent. For the majority of species/drug combinations a mixture of diameter change patterns was found. These different patterns are most probably related to different phenotype entities, e.g. WT isolates and different non-WT populations. A specific analysis of the interdependence of resistance mechanisms and diameter change patterns is beyond the scope of this study, but will be essential for developing a reliable interpretation system for disc diffusion reading at early timepoints.
As existing CBPs of EUCAST and CLSI cannot be used to categorize zone diameters that are read at early timepoints, specific cutoffs for rAST must be used. Three settings can be distinguished that influence these time-dependent cut-offs (TDCs). (i) If diameter values are stable over time and/or no category changes occur over time for all WT and non-WT populations of a given species/ drug combination, existing CLSI/EUCAST CBPs could readily be used as few interpretation errors occur, e.g. for ceftriaxone and E. coli (see Figure 1a) . (ii) If zone diameters change over time and category changes occur, but susceptible and resistant populations can be discriminated at early reading times, TDCs may be set based on WT/non-WT populations as is done by EUCAST for the standard system using epidemiological cut-off values (ECOFFs). At 6, 8 or 12 h, ECOFFs could be determined and used as putative early CBPs, e.g. for S. aureus and cefoxitin (Figure 1c) . (iii) If zone diameters change over time and resistant populations cannot be Hombach et al. Table 2 . Early reading of disc diffusion susceptibility tests with clinical strains of E. coli (n " 291), K. pneumoniae (n " 272), S. aureus (n " 176) and S. epidermidis (n " 
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discriminated at early reading times, a buffer zone would be useful. Such a zone of methodological uncertainty (ZMU; e.g. for S. aureus and penicillin G; Figure 1b ) would cover borderline isolates whose classification as either susceptible or resistant is uncertain. The definition of ZMUs could be supported by early ECOFFs defining the WT population and the resistant cut-offs (RCOFFs) delineating the non-WT populations. 30 All isolates within the ZMU, i.e. in the overlapping part of WT and non-WT populations, would be categorized as 'uncertain' and should not be reported at early reading.
To define such TDCs and ZMUs, it will be necessary to test and analyse defined WT and non-WT populations and to expand rAST to other groups/genera than those contained in this work.
In summary, our study demonstrates several key findings: (i) early reading is possible for the most frequently encountered pathogens from blood cultures; (ii) precision of disc diffusion ASTs is not hampered by early reading; (iii) zone diameters change over time and may result in both major and very major errors when applying existing 18 h based CBPs of CLSI/EUCAST; (iv) patterns of Rapid disc diffusion susceptibility testing JAC inhibition zone diameter changes are phenotype/drug combination dependent; and (v) specific expert rules and cut-offs will be necessary to allow for reliable interpretation and reporting of rAST results.
